Literature DB >> 23852377

Effect of all-trans retinoic acid on the differentiation of U87 glioma stem/progenitor cells.

Zhe Shi1, Meiqing Lou, Yaodong Zhao, Quanbin Zhang, Daming Cui, Ke Wang.   

Abstract

GSPCs (glioma stem/progenitor cells) were isolated from U87 glioma cell lines by serum-free neural stem cell medium. Four concentrations (1, 2, 4, and 8 μmol/L) of ATRA (all-trans retinoic acid) were used to induce the differentiation of GSPCs in the medium with or without growth factors. The effect of ATRA on the differentiation of GSPCs was analyzed by flow cytometry, real-time-PCR, and immunofluorescence. The differentiation of GSPCs could be induced by 1 or 2 μmol/L ATRA when GSPCs were cultured in growth factor-free medium. The detection of real-time-PCR showed that the level of GFAP (glial fibrillary acidic protein) mRNA of differentiated GSPCs in the growth factor-free medium containing 1 μmol/L ATRA group was significantly higher than that in the control group, and there was no significant difference in the level of TUBB-3 mRNA between the two groups. The GSPCs suffered apoptosis in the growth factor-free medium containing 4 or 8 μmol/L ATRA. The differentiation of GSPCs could not be induced by ATRA when GSPCs were cultured in the medium containing growth factors. The percentage of cells in G0/G1 phase was 84.26 ± 2.24 %, and the percentage of apoptosis was 18.95 ± 2.53 % in experimental groups which was similar to those in the control group. In conclusion, ATRA has certain capacity to induce differentiation of GSPCs, while its effective concentration should be controlled strictly. The differentiation of GSPCs induced by ATRA cannot antagonize the formidable differential inhibition of epidermal growth factor and basic fibroblast growth factor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852377     DOI: 10.1007/s10571-013-9960-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  22 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

Review 2.  Retinoic acid signalling during development.

Authors:  Muriel Rhinn; Pascal Dollé
Journal:  Development       Date:  2012-03       Impact factor: 6.868

3.  [Differentiation of neonatal rat striatal neural stem cells induced by all-trans retinoic acid].

Authors:  Hong Deng; Fei Zou; Hai-ji Luo
Journal:  Di Yi Jun Yi Da Xue Xue Bao       Date:  2005-11

4.  Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid).

Authors:  R A Quirk; W C Chan; M C Davies; S J Tendler; K M Shakesheff
Journal:  Biomaterials       Date:  2001-04       Impact factor: 12.479

5.  Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins.

Authors:  Paola Zancai; Jessica Dal Col; Sara Piccinin; Massimo Guidoboni; Roberta Cariati; Silvana Rizzo; Mauro Boiocchi; Roberta Maestro; Riccardo Dolcetti
Journal:  Oncogene       Date:  2005-04-07       Impact factor: 9.867

6.  CRABP-II methylation: a critical determinant of retinoic acid resistance of medulloblastoma cells.

Authors:  Yuan-Shan Fu; Qian Wang; Jing-Xin Ma; Xiang-Hong Yang; Mo-Li Wu; Kai-Li Zhang; Qing-You Kong; Xiao-Yan Chen; Yuan Sun; Nan-Nan Chen; Xiao-Hong Shu; Hong Li; Jia Liu
Journal:  Mol Oncol       Date:  2011-11-25       Impact factor: 6.603

Review 7.  Retinoids regulate stem cell differentiation.

Authors:  Lorraine J Gudas; John A Wagner
Journal:  J Cell Physiol       Date:  2011-02       Impact factor: 6.384

8.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

9.  All-trans retinoic acid inhibits KIT activity and induces apoptosis in gastrointestinal stromal tumor GIST-T1 cell line by affecting on the expression of survivin and Bax protein.

Authors:  Thanh Chi Hoang; Thi Kim Ly Bui; Takahiro Taguchi; Toshiki Watanabe; Yuko Sato
Journal:  J Exp Clin Cancer Res       Date:  2010-12-16

10.  TRAIL and paclitaxel synergize to kill U87 cells and U87-derived stem-like cells in vitro.

Authors:  Bo Qiu; Xiyang Sun; Dongyong Zhang; Yong Wang; Jun Tao; Shaowu Ou
Journal:  Int J Mol Sci       Date:  2012-07-20       Impact factor: 6.208

View more
  4 in total

Review 1.  Retinoic acid signaling and neuronal differentiation.

Authors:  Amanda Janesick; Stephanie Cherie Wu; Bruce Blumberg
Journal:  Cell Mol Life Sci       Date:  2015-01-06       Impact factor: 9.261

Review 2.  Deregulated proliferation and differentiation in brain tumors.

Authors:  Fredrik J Swartling; Matko Čančer; Aaron Frantz; Holger Weishaupt; Anders I Persson
Journal:  Cell Tissue Res       Date:  2014-11-23       Impact factor: 5.249

3.  Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma.

Authors:  Ke Wang; Dongjiang Chen; Zhouqi Qian; Daming Cui; Liang Gao; Meiqing Lou
Journal:  Cancer Cell Int       Date:  2017-12-04       Impact factor: 5.722

4.  All-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation.

Authors:  Geng-Qiang Ling; Yi-Jing Liu; Yi-Quan Ke; Lei Chen; Xiao-Dan Jiang; Chuan-Lu Jiang; Wei Ye
Journal:  Mol Med Rep       Date:  2015-03-06       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.